Article
Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer.
Experimental dermatology - 1 Jun 2009
Bauer Jürgen, Weng Julie, Kebebew Electron, Soares Paula, Trovisco Vitor, Bastian Boris C
Abstract excerpt
BACKGROUND: Recently, germline variants of the melanocortin-1 receptor (MC1R) have been shown to be associated with an increased risk for BRAF mutant but not BRAF wild-type cutaneous melanoma. Similar to melanoma, BRAF mutations are also commonly found in papillary thyroid carcinomas. Furthermore...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
